|
1.
|
|
135 p, 1.9 MB |
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias : An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
/
Lewczuk, Piotr (University Hospital of Białystok) ;
Riederer, Peter (University Hospital Würzburg) ;
O'Bryant, Sid E. (University of North Texas Health Science Center) ;
Verbeek, Marcel M. (Radboud Alzheimer center) ;
Dubois, Bruno (Salpêtrièrie Hospital) ;
Visser, Pieter Jelle (Vrije Universiteit Amsterdam) ;
Jellinger, Kurt A. (Institute of Clinical Neurobiology) ;
Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ;
Ramirez, Alfredo (University of Cologne) ;
Parnetti, Lucilla (University of Perugia) ;
Jack Jr, Clifford R. (Mayo Clinic) ;
Teunissen, Charlotte E. (VU University Medical Center Amsterdam) ;
Hampel, Harald (heimer (IM2A). Hôpital Pitié-Salpêtrière) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Jessen, Frank (German Center for Neurodegenerative Disorders (DZNE)) ;
Glodzik, Lidia (NYU Langone Medical Center) ;
de Leon, Mony J. (NYU Langone Medical Center) ;
Fagan, Anne M. (Washington University School of Medicine) ;
Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ;
Jansen, Willemijn J. (Maastricht University) ;
Winblad, Bengt (Karolinska Institutet (Estocolm, Suècia)) ;
Shaw, Leslie M. (University of Pennsylvania) ;
Andreasson, Ulf (The Sahlgrenska Academy at the University of Gothenburg) ;
Otto, Markus (University of Ulm) ;
Mollenhauer, Brit (Kassel and University Medical Center Göttingen) ;
Wiltfang, Jens (University of Aveiro) ;
Turner, Martin R. (University of Oxford) ;
Zerr, Inga (German Center for Neurodegenerative Diseases) ;
Handels, Ron (Karolinska Institutet (Estocolm, Suècia)) ;
Thompson, Alexander G. (University of Oxford) ;
Johansson, Gunilla (Karolinska Institutet (Estocolm, Suècia)) ;
Ermann, Natalia (Universitätsklinikum Erlangen. and Friedrich-Alexander Universität Erlangen-Nürnberg) ;
Trojanowski, John Q. (University of Pennsylvania) ;
Karaca, Ilker (University of Bonn) ;
Wagner, Holger (University of Bonn) ;
Oeckl, Patrick (University of Ulm) ;
van Waalwijk van Doorn, Linda (Radboud Alzheimer center) ;
Bjerke, Maria (University of Antwerp) ;
Kapogiannis, Dimitrios (National Institute on Aging/National Institutes of Health (NIA/NIH)) ;
Kuiperij, H.Bea (Radboud Alzheimer center) ;
Farotti, Lucia (University of Perugia) ;
Li, Yi (NYU Langone Medical Center) ;
Gordon, Brian A. (Washington University School of Medicine) ;
Epelbaum, Stéphane (Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A)) ;
Vos, Stephanie J.B. (Maastricht University) ;
Klijn, Catharina J.M. (Radboud Alzheimer Center) ;
Van Nostrand, William E. (Stony Brook University) ;
Minguillon, Carolina (Fundació Pasqual Maragall) ;
Schmitz, Matthias (University Medical School) ;
Gallo, Carla (Universidad Peruana Cayetano Heredia) ;
Lopez Mato, Andrea (Maimonides University) ;
Thibaut, Florence (University Hospital Cochin-Site Tarnier 89 rue d'Assas) ;
Lista, Simone (heimer (IM2A). Hôpital Pitié-Salpêtrière) ;
Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ;
Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ;
Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ;
Kornhuber, Johannes (Universitätsklinikum Erlangen) ;
Universitat Autònoma de Barcelona
In the 12 years since the publication of the first Consensus Paper of the WFSBP on biomarkers of neurodegenerative dementias, enormous advancement has taken place in the field, and the Task Force takes now the opportunity to extend and update the original paper. [...]
2018 -  10.1080/15622975.2017.1375556
World Journal of Biological Psychiatry, Vol. 19 Núm. 4 (19 2018) , p. 244-328
|
|
|
2.
|
|
13 p, 1.3 MB |
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid
/
Gobom, Johan (Clinical Neurochemistry Laboratory. Sahlgrenska University Hospital) ;
Parnetti, Lucilla (Laboratory of Clinical Neurochemistry. Section of Neurology. University of Perugia) ;
Rosa-Neto, Pedro (Montreal Neurological Institute) ;
Vyhnalek, Martin (International Clinical Research Center. St. Anne's University Hospital) ;
Gauthier, Serge (Montreal Neurological Institute) ;
Cataldi, Samuela (Laboratory of Clinical Neurochemistry. Section of Neurology. University of Perugia) ;
Lerch, Ondrej (International Clinical Research Center. St. Anne's University Hospital) ;
Laczo, Jan (International Clinical Research Center. St. Anne's University Hospital) ;
Cechova, Katerina (International Clinical Research Center. St. Anne's University Hospital) ;
Clarin, Marcus (Clinical Neurochemistry Laboratory. Sahlgrenska University Hospital) ;
Benet, Andrea L. (Translational Neuroimaging Laboratory. McGill Centre for Studies in Aging. McGill University) ;
Pascoal, Tharick A. (Translational Neuroimaging Laboratory. McGill Centre for Studies in Aging. McGill University) ;
Rahmouni, Neserine (Translational Neuroimaging Laboratory. McGill Centre for Studies in Aging. McGill University) ;
Vandijck, Manu (Fujirebio Europe N.V.) ;
Huyck, Else (Fujirebio Europe N.V.) ;
Le Bastard, Nathalie (Fujirebio Europe N.V.) ;
Stevenson, Jenna (Translational Neuroimaging Laboratory. McGill Centre for Studies in Aging. McGill University) ;
Chamoun, Mira (Translational Neuroimaging Laboratory. McGill Centre for Studies in Aging. McGill University) ;
Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Andreasson, Ulf (Clinical Neurochemistry Laboratory. Sahlgrenska University Hospital) ;
Verbeek, Marcel M. (Department of Neurology. Radboud Alzheimer Centre. Radboud University Medical Center. Donders Institute for Brain. Cognition and Behaviour) ;
Bellomo, Giovanni (Laboratory of Clinical Neurochemistry. Section of Neurology. University of Perugia) ;
Rinaldi, Roberta (Laboratory of Clinical Neurochemistry. Section of Neurology. University of Perugia) ;
Ashton, Nicholas J. (NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation) ;
Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit). UK Dementia Research Institute) ;
Sheardova, Katerina (First Department of Neurology. Faculty of Medicine. Masaryk University. St. Anne's University Hospital) ;
Hort, Jakub (First Department of Neurology. Faculty of Medicine. Masaryk University. St. Anne's University Hospital) ;
Blennow, Kaj (Clinical Neurochemistry Laboratory. Sahlgrenska University Hospital) ;
Universitat Autònoma de Barcelona
Objectives: The core cerebrospinal fluid (CSF) biomarkers; total tau (tTau), phospho-tau (pTau), amyloid β 1-42 (Aβ 1-42), and the Aβ 1-42/Aβ 1-40 ratio have transformed Alzheimer's disease (AD) research and are today increasingly used in clinical routine laboratories as diagnostic tools. [...]
2022 - 10.1515/cclm-2021-0651
Clinical Chemistry and Laboratory Medicine, Vol. 60 Núm. 2 (january 2022) , p. 207-219
|
|
|
3.
|
|
12 p, 312.7 KB |
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease : An international overview
/
Delaby, Constance (Institut d'Investigació Biomèdica Sant Pau) ;
Teunissen, Charlotte E. (Vrije Universiteit Amsterdam) ;
Blennow, Kaj (The Sahlgrenska Academy at the University of Gothenburg) ;
Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ;
Arisi, Ivan (European Brain Research Institute (EBRI) "Rita Levi-Montalcini") ;
Amar, Elodie Bouaziz (GHU APHP Nord Lariboisière Fernand-Widal Hospital) ;
Beaume, Anne (CHU Poitiers) ;
Bedel, Aurelie (CHU Bordeaux) ;
Bellomo, Giovanni (University of Perugia) ;
Bigot-Corbel, Edith (CHU de Nantes) ;
Bjerke, Maria (University of Antwerp) ;
Blanc-Quintin, Marie-Céline (APHP Centre-Université de Paris, Cochin Hospital) ;
Boada, Mercè (Instituto de Salud Carlos III) ;
Bousiges, Olivier (Hôpitaux Universitaires de Strasbourg) ;
Chapman, Miles D (National Hospital for Neurology and Neurosurgery, UCL Queen Square) ;
DeMarco, Mari L. (University of British Columbia) ;
D'Onofrio, Mara (European Brain Research Institute (EBRI) "Rita Levi-Montalcini") ;
Dumurgier, Julien (GHU APHP Nord Lariboisière Fernand-Widal Hospital) ;
Dufour-Rainfray, Diane (CHU Tours) ;
Engelborghs, Sebastiaan (Center for Neurosciences and Department of Neurology) ;
Esselmann, Hermann (University Medical Center Goettingen (UMG) ;
Fogli, Anne (CHU Clermont-Ferrand) ;
Gabelle, Audrey (INSERM) ;
Galloni, Elisabetta (Dipartimento di Neuroscienze Divisione di Neurologia) ;
Gondolf, Clémentine (CHU Cote de Nacre Caen) ;
Grandhomme, Frédérique (CHU Cote de Nacre Caen) ;
Grau-Rivera, Oriol (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Hart, Melanie (National Hospital for Neurology and Neurosurgery, UCL Queen Square) ;
Ikeuchi, Takeshi (Niigata University) ;
Jeromin, Andreas (Cohen Veterans Bioscience) ;
Kasuga, Kensaku (Niigata University) ;
Keshavan, Ashvini (UCL Institute of Neurology (Regne Unit)) ;
Khalil, Michael (Medical University of Graz) ;
Körtvelyessy, Peter (German Center for Neurodegenerative Diseases, Magdeburg, Germany and Charité-Universitäts medizin Berlin) ;
Kulczynska-Przybik, Agnieszka (Medical University of Bialystok) ;
Laplanche, Jean-Louis (GHU APHP Nord Lariboisière Fernand-Widal Hospital) ;
Lewczuk, Piotr (Universitätsklinikum Erlangen and Friedrich-Alexander Universität Erlangen-Nürnberg) ;
Li, Qiao-Xin (Florey Institute and The University of Melbourne) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Malaplate, Catherine (Biologie Moléculaire et Nutrition/ Université de Lorraine) ;
Marquié, Marta (Instituto de Salud Carlos III) ;
Masters, Colin L. (Florey Institute and The University of Melbourne) ;
Mroczko, Barbara (Medical University of Bialystok) ;
Nogueira, Léonor (CHU PURPAN) ;
Orellana, Adelina (Instituto de Salud Carlos III) ;
Otto, Markus (University of Ulm) ;
Oudart, Jean-Baptiste (Université de Reims Champagne-Ardenne) ;
Paquet, Claire (GHU APHP Nord Lariboisière Fernand-Widal Hospital) ;
Paoletti, Federico Paolini (University of Perugia) ;
Parnetti, Lucilla (University of Perugia) ;
Perret-Liaudet, Armand (Lyon University Hospital) ;
Peoc'h, Katell (Université de Paris GHU APHP Nord Beaujon Hospital) ;
Poesen, Koen (Leuven Brain Institute) ;
Puig-Pijoan, Albert (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Quadrio, Isabelle (Lyon University Hospital) ;
Quillard-Muraine, Muriel (Normandie Univ) ;
Rucheton, Benoit (AP-HP Sorbonne University) ;
Schraen, Susanna (Université de Lille) ;
Schott, Jonathan M. (UCL Institute of Neurology (Regne Unit)) ;
Shaw, Leslie M. (University of Pennsylvania) ;
Suárez-Calvet, Marc (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Tsolaki, Magda (Aristotle University of Thessaloniki) ;
Tumani, Hayrettin (University of Ulm) ;
Udeh-Momoh, Chinedu T (Imperial College London) ;
Vaudran, Lucie (Univ. Lille) ;
Verbeek, Marcel M (Radboud University Medical Center) ;
Verde, Federico ("Dino Ferrari" Center, Università degli Studi di Milano) ;
Vermunt, Lisa (Vrije Universiteit Amsterdam) ;
Vogelgsang, Jonathan (Harvard Medical School) ;
Wiltfang, Jens (University of Aveiro) ;
Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ;
Lehmann, Sylvain (Université de Montpellier) ;
Universitat Autònoma de Barcelona
The current practice of quantifying cerebrospinal fluid (CSF) biomarkers as an aid in the diagnosis of Alzheimer's disease (AD) varies from center to center. For a same biochemical profile, interpretation and reporting of results may differ, which can lead to misunderstandings and raises questions about the commutability of tests. [...]
2021 - 10.1002/alz.12545
Alzheimer's & Dementia, Vol. 18 (december 2021) , p. 1868-1879
|
|
|
4.
|
|
5 p, 885.6 KB |
Correction to : Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies
/
Opladen, Thomas (University Children's Hospital (Alemanya)) ;
López-Laso, Eduardo (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ;
Cortès-Saladelafont, Elisenda (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pearson, Toni S. (Washington University School of Medicine. Department of Neurology) ;
Sivri, H. Serap (Hacettepe University) ;
Yildiz, Yilmaz (Hacettepe University) ;
Assmann, Birgit (University Children's Hospital) ;
Kurian, Manju A. (Great Ormond Street Hospital for Children (Londres)) ;
Leuzzi, Vincenzo (Sapienza University of Rome. Unit of Child Neurology and Psychiatry, Department of Human Neuroscience) ;
Heales, Simon (National Hospital (Regne Unit)) ;
Pope, Simon (National Hospital (Regne Unit)) ;
Porta, Francesco (AOU Città della Salute e della Scienza. Department of Pediatrics (Itàlia)) ;
García-Cazorla, Angels (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Honzík, Tomáš (Charles University) ;
Pons, Roser (Aghia Sofia Hospital) ;
Regal, Luc (Pediatric Neurology and Metabolism Unit (Bèlgica)) ;
Goez, Helly (University of Alberta Glenrose Rehabilitation Hospital. Department of Pediatrics) ;
Artuch, R. (Institut de Recerca Sant Joan de Déu) ;
Hoffmann, Georg F. (University Children's Hospital. Division of Child Neurology and Metabolic Disorders) ;
Horvath, Gabriella (University of British Columbia. Department of Pediatrics, Division of Biochemical Genetics) ;
Thöny, Beat (University Children's Hospital Zurich) ;
Scholl-Bürgi, Sabine (Medical University of Innsbruck) ;
Burlina, Alberto (Azienda Ospedaliera Universitaria di Padova) ;
Verbeek, Marcel M. (Radboud University Medical Centre. Departments of Neurology and Laboratory Medicine) ;
Mastrangelo, Mario (Sapienza University of Rome) ;
Friedman, Jennifer (Rady Children's Institute for Genomic Medicine) ;
Wassenberg, Tessa (Pediatric Neurology and Metabolism Unit (Bèlgica)) ;
Jeltsch, Kathrin (University Children's Hospital) ;
Kulhánek, Jan (Charles University) ;
Kuseyri Hübschmann, Oya (University Children's Hospital) ;
Universitat Autònoma de Barcelona
2020 - 10.1186/s13023-020-01464-y
Orphanet Journal of Rare Diseases, Vol. 15 (august 2020)
|
|
|
5.
|
|
13 p, 610.0 KB |
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers
/
van Waalwijk van Doorn, Linda J. C. ;
Ghafoorian, Mohsen ;
van Leijsen, Esther M. C. ;
Claassen, Jurgen A. H. R. ;
Arighi, Andrea ;
Bozzali, Marco ;
Cannas, Jorge ;
Cavedo, Enrica ;
Eusebi, Paolo ;
Farotti, Lucia ;
Fenoglio, Chiara ;
Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Frisoni, Giovanni B. ;
Galimberti, Daniela ;
Greco, Viviana ;
Herukka, Sanna-Kaisa ;
Liu, Yawu ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
de Mendonça, Alexandre ;
Nobili, Flavio M. ;
Parnetti, Lucilla ;
Picco, Agnese ;
Pikkarainen, Maria ;
Salvadori, Nicola ;
Scarpini, Elio ;
Soininen, Hilkka ;
Tarducci, Roberto ;
Urbani, Andrea ;
Vilaplana, Eduard (Institut d'Investigació Biomèdica Sant Pau) ;
Meulenbroek, Olga ;
Platel, Bram ;
Verbeek, Marcel M. ;
Kuiperij, H. Bea ;
Universitat Autònoma de Barcelona
The cerebrospinal fluid (CSF) biomarkers amyloid-β 1-42 (Aβ), total and phosphorylated tau (t-tau, p-tau) are increasingly used to assist in the clinical diagnosis of Alzheimer's disease (AD). However, CSF biomarker levels can be affected by confounding factors. [...]
2021 - 10.3233/JAD-200496
Journal of Alzheimer's disease, Vol. 79 (january 2021) , p. 163-175
|
|
|
6.
|
|
30 p, 1.7 MB |
Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH) deficiencies
/
Opladen, Thomas (University Children's Hospital. Division of Child Neurology and Metabolic Disorders) ;
López-Laso, Eduardo (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Cortès-Saladelafont, Elisenda (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pearson, Toni S. (Washington University School of Medicine. Department of Neurology) ;
Sivri, H. Serap (Hacettepe University, Faculty of Medicine. Department of Pediatrics, Section of Metabolism) ;
Yildiz, Yilmaz (Hacettepe University, Faculty of Medicine. Department of Pediatrics, Section of Metabolism) ;
Assmann, Birgit (University Children's Hospital. Division of Child Neurology and Metabolic Disorders) ;
Kurian, Manju A. (Great Ormond Street Hospital for Children (Londres)) ;
Leuzzi, Vincenzo (Sapienza University of Rome. Unit of Child Neurology and Psychiatry, Department of Human Neuroscience) ;
Heales, Simon (National Hospital. Neurometabolic Unit) ;
Pope, Simon (National Hospital. Neurometabolic Unit) ;
Porta, Francesco (AOU Città della Salute e della Scienza. Department of Pediatrics) ;
García-Cazorla, Angels (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Honzík, Tomáš (Charles University. Faculty of Medicine in Hradec Králové) ;
Pons, Roser (Aghia Sofia Hospital. First Department of Pediatrics of the University of Athens) ;
Regal, Luc (UZ Brussel. Department of Pediatric, Pediatric Neurology and Metabolism Unit) ;
Goez, Helly (University of Alberta Glenrose Rehabilitation Hospital. Department of Pediatrics) ;
Artuch, R. (Institut de Recerca Sant Joan de Déu) ;
Hoffmann, Georg F. (University Children's Hospital. Division of Child Neurology and Metabolic Disorders) ;
Horvath, Gabriella (University of British Columbia. Department of Pediatrics, Division of Biochemical Genetics, BC Children's Hospital) ;
Thöny, Beat (University Children's Hospital Zurich. Division of Metabolism) ;
Scholl-Bürgi, Sabine (Medical University of Innsbruck. Clinic for Pediatrics I) ;
Burlina, Alberto (Azienda Ospedaliera Universitaria di Padova) ;
Verbeek, Marcel M. (Radboud University Medical Centre. Departments of Neurology and Laboratory Medicine) ;
Mastrangelo, Mario (Sapienza University of Rome. Unit of Child Neurology and Psychiatry, Department of Human Neuroscience) ;
Friedman, Jennifer (Rady Children's Hospital Division of Neurology; Rady Children's Institute for Genomic Medicine. UCSD Departments of Neuroscience and Pediatrics) ;
Wassenberg, Tessa (UZ Brussel. Department of Pediatric, Pediatric Neurology and Metabolism Unit) ;
Jeltsch, Kathrin (University Children's Hospital. Division of Child Neurology and Metabolic Disorders) ;
Kulhánek, Jan (Charles University. Faculty of Medicine in Hradec Králové) ;
Kuseyri Hübschmann, Oya (University Children's Hospital. Division of Child Neurology and Metabolic Disorders) ;
Universitat Autònoma de Barcelona
Tetrahydrobiopterin (BH) deficiencies comprise a group of six rare neurometabolic disorders characterized by insufficient synthesis of the monoamine neurotransmitters dopamine and serotonin due to a disturbance of BH biosynthesis or recycling. [...]
2020 - 10.1186/s13023-020-01379-8
Orphanet Journal of Rare Diseases, Vol. 15 (may 2020)
|
|
|
7.
|
|
8 p, 444.3 KB |
White paper by the Society for CSF Analysis and Clinical Neurochemistry : Overcoming barriers in biomarker development and clinical translation
/
Teunissen, Charlotte E. (Amsterdam, The Netherlands) ;
Otto, Markus (Ulm, Germany) ;
Engelborghs, Sebastiaan (Antwerp, Belgium) ;
Herukka, Sanna-Kaisa (Kuopio, Finland) ;
Lehmann, Sylvain (University Hospital of Montpellier (França)) ;
Lewczuk, Piotr (Białystok, Poland) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Perret-Liaudet, Armand (Lyon, France) ;
Tumani, Hayrettin (Schwendi, Germany) ;
Turner, Martin R. (Oxford, UK) ;
Verbeek, Marcel M. (Radboud University Medical Centre. Departments of Neurology and Laboratory Medicine) ;
Wiltfang, Jens (Aveiro, Portugal) ;
Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit). UK Dementia Research Institute) ;
Parnetti, Lucilla (Perugia, Italy) ;
Blennow, Kaj (Mölndal, Sweden) ;
Universitat Autònoma de Barcelona
Body fluid biomarkers have great potential for different clinical purposes, including diagnosis, prognosis, patient stratification and treatment effect monitoring. This is exemplified by current use of several excellent biomarkers, such as the Alzheimer's disease cerebrospinal fluid (CSF) biomarkers, anti-neuromyelitis optica antibodies and blood neurofilament light. [...]
2018 - 10.1186/s13195-018-0359-x
Alzheimer's research & therapy, Vol. 10 (march 2018)
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
